Study on the Effective Prevention and Control of Maize Rough Dwarf Disease in Different Areas with Varying Epidemic Intensity in Shandong Province

[ Objective] This study aimed to investigate the effective prevention and control of maize rough dwarf disease in different areas with varying epidemic inten-sity in Shandong Province. [Method] Control effects of single application of virus in-hibitors and composite application of virus inhibitors with seed dressing agents and pesticides on maize rough dwarf disease in different areas with varying epidemic intensity were investigated. [Result] The same treatment possessed entirely different effects in severely affected areas and slightly affected areas. To be specific, single application of virus inhibitors in slightly affected areas exhibited good control effects, with a control efficiency of 76.59% and yield increment rate of 158.21%; in severely affected areas, single application of virus inhibitors led to low control efficiency and yield increment rate. The highest control efficiency of composite application of virus inhibitors with seed dressing agents and pesticides in severely affected areas was 71.38%, and experimental plots changed from total crop failure to have certain eco-nomic output. [Conclusion] ln different areas with varying epidemic intensity of maize rough dwarf disease, different application modes should be adopted according to lo-cal conditions, thereby saving cost and improving control efficiency.

Study on Screening of Virus Inhibitor Combinations against Viral Diseases in Chinese Cabbage

In this study, several kinds of virus inhibitors or passivators, such as Dufulin and lentinan, were used to design 15 individual or combination treatments, to investigate their control efficiency against viral diseases in Chinese cabbage. Re- sults showed that individual treatments of Dufulin and lentinan achieved high control efficiency of 70.01% and 66.02%, respectively; combination treatments of Dufulin ＋ lentinan, Dufulin ＋ Weijiaxi and Lentinan ＋Weijiaxi also produced certain synergistic effects, with control efficiency of 83.70%, 78.07% and 82.32%, respectively.

蚌埠市1996～1999年急性迟缓性麻痹病例监测系统评价

目的 评价急性迟缓性麻痹 (AFP)病例监测系统。方法 对 1996～ 1999年蚌埠地区AFP病例监测系统资料采用 Epi Info软件进行统计分析。结果 共报告 AFP病 6 2例 ,每年 15 a以下儿童 AFP病例报告发病率达到 1.32 / 10万。 AFP病例 48h内调查率 95 .16 % ,14d内双份合格粪便标本采集率 90 .32 % ,粪便标本 7d内送至省卫生防疫站占 87.10 %。零病例旬报及时率96 .46 % ,麻痹 6 0 d后随访并将随访表 75 d内送至省卫生防疫站占 91.94% ,AFP病例就诊 2 4h内报告率 75 .81%。结论 蚌埠市 AFP病例监测系统各项监测指标已达到规划要求。

HIV/AIDS in Asia:The Shape of Epidemics and Their Molecular Epidemiology

The Asia-Pacific region is a home to 60% of the population in the world and to approximately one quarter of people with HIV/AIDS. Close to a million of people has been infected and a half million people died of AIDS annually in Asia,becoming the second largest epicenter of global AIDS epidemic. Molecular epidemiology has been useful tool to track a course of HIV spread. In-depth knowledge from the studies on molecular epidemiology elucidates the dynamics of HIV spread and the interrelationship of epidemics in the different regions in Asia.

AIDS Research and Its Role in China's AIDS Prevention and Control Policies

By the end of 2005,the estimated number of HIV infected people in China was 650,000. The seriousness of the epidemic calls for effective control measures to tackle the problems in order to avoid the tragedy in Africa from happening in China. "Prevention First" is the cornerstone of the country's health policy. On 2003 World AIDS Day,Premier Jiabao Wen announced a new national AIDS control policy,"Four Frees and One Care". This policy clearly shows that the Chinese government has once again taken full responsibility to solve public health problems and has profound impact far beyond the AIDS field. In early 2006,the central government put scientific and technology innovation as a national priority and set the target to build an innovative China by year 2020. Since then,the government has been increasing investment in science and technology with major emphasis on both infectious diseases control and new drug research and development. For the first time,development of 100 new drugs and control of major infectious diseases (AIDS,HBV,TB and other emerging infectious diseases) have been selected as national key scientific projects. China's best minds in related fields will be pooled to work together in order to remove the technical barriers blocking efficient control of the major infectious disease in China. Knowledge on molecular epidemiology,immunology,pathogenesis,HAART,as well as HIVDR strains will certainly provide urgently needed scientific information for China's AIDS control program. Only evidence-based strategy from good research will provide long-term effective control of AIDS.

Challenges and Opportunities:the Expanded Government-led HIV/AIDS Programs in China

HIV/AIDS has posed an increasingly serious issue in China. In recent years,Chinese government has taken further intensified efforts to combat HIV/AIDS with high-level political commitment,supportive policy development,increased financial allocation,large-scale of government-led initiatives,expanded international cooperation and great involvement of non-governmental organizations. Meanwhile gaps and challenges coexist impacting the implementation and the results of national HIV/AIDS programs. Thus,further government efforts are needed to improve and tailor the actions to meet the requirement of HIV/AIDS control in China.